Population Pharmacokinetics of Dalbavancin and Dosing Consideration for Optimal Treatment of Adult Patients with Staphylococcal Osteoarticular Infections

Dalbavancin is gaining interest in the treatment of complex osteoarticular (OA) infections. We aimed to conduct a population pharmacokinetic analysis of dalbavancin in a prospective cohort of adult patients with OA infections caused by Gram-positive organisms and to identify optimal dosing regimens...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Antimicrob Agents Chemother
Auteurs principaux: Cojutti, Pier Giorgio, Rinaldi, Matteo, Zamparini, Eleonora, Rossi, Nicolò, Tedeschi, Sara, Conti, Matteo, Pea, Federico, Viale, Pierluigi
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2021
Sujets:
Clinical Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8092885/
https://ncbi.nlm.nih.gov/pubmed/33649108
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02260-20
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires